CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Wuhan Jianmin Pharmaceutical Group Co., Ltd. Company Snapshot
Wuhan Jianmin Pharmaceutical Group Co., Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Wuhan Jianmin Pharmaceutical Group Co., Ltd. with three other companies in this sector in China: Chengdu Kanghong Pharmaceutical Group Co Ltd (2017 sales of 2.79 billion Chinese Renmimbi [US$402.20 million] of which 100% was Pharmaceutical Manufacturing), SSY Group Ltd (2.66 billion Chinese Renmimbi [US$383.66 million] of which 96% was Intravenous Infusion Solution and Others), and Sihuan Pharmaceutical Holdings Group Ltd (2.75 billion Chinese Renmimbi [US$396.33 million] of which 100% was Pharmaceutical Prods).

Sales Analysis. Wuhan Jianmin Pharmaceutical Group Co., Ltd. reported sales of 2.71 billion Chinese Renmimbi (US$391.38 million) for the year ending December of 2017. This represents an increase of 14.7% versus 2016, when the company's sales were 2.36 billion Chinese Renmimbi. This was the third consecutive year of growth at Wuhan Jianmin Pharmaceutical Group Co., Ltd.. Sales of Pharmaceutical saw an increase of 23.5% in 2017, from 855.80 million Chinese Renmimbi to 1.06 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Wuhan Jianmin Pharmaceutical Group Co., Ltd.
  Stock Performance Chart for Wuhan Jianmin Pharmaceutical Group Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/19/2018): 14.49
(Figures in Chinese Renmimbi)
1 Week -3.7%   13 Weeks -17.3%  
4 Weeks -28.4%   52 Weeks -50.5%  
 
Wuhan Jianmin Pharmaceutical Group Co., Ltd. Key Data:
  Ticker: 600976 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 2,711,502,823
(Year Ending Jan 2018).
Employees: 1,861
  Currency: Chinese Renmimbi Market Cap: 2,222,745,714
  Fiscal Yr Ends: December Shares Outstanding: 153,398,600
  Share Type: A Gu Closely Held Shares: 35,840,823
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.